Inactive Instrument
Medicure Inc Share Price Toronto S.E.
Stocks
MPH
CA58469E4085
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 11.17M 7.94M 6.94M 6.42M 5.93M 763M 11.37M 76.54M 30.03M 374M 29.84M 29.18M 1.29B | P/E 2024 |
-8.8x | P/E 2025 | -1.68x |
|---|---|---|---|---|---|
| Enterprise Value | 8.22M 5.85M 5.11M 4.73M 4.37M 562M 8.37M 56.36M 22.11M 275M 21.97M 21.49M 947M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.31x |
| Free-Float |
72.7% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Medicure Inc
| 1 day | -5.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CEO | Chief Executive Officer | 79 | 14/09/1997 |
Haaris Uddin
DFI | Director of Finance/CFO | - | 31/05/2022 |
Reuben Saba
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CHM | Chairman | 79 | 14/09/1997 |
Arnold Naimark
BRD | Director/Board Member | 92 | 27/02/2000 |
Brent Fawkes
BRD | Director/Board Member | 56 | 21/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.23% | +0.16% | - | - | 7.68M | ||
| +6.05% | +7.79% | +62.23% | +88.46% | 53.54B | ||
| +0.21% | -6.28% | +56.18% | +127.90% | 54.18B | ||
| +0.89% | -2.42% | +8.07% | +434.51% | 23.66B | ||
| +0.37% | -4.13% | -18.56% | -16.48% | 22.78B | ||
| -1.83% | +5.16% | +37.36% | -8.20% | 19.54B | ||
| -2.29% | -1.92% | +35.57% | -29.14% | 17.82B | ||
| -4.00% | -10.96% | +181.91% | +328.17% | 16.01B | ||
| +1.16% | +5.13% | +40.94% | +671.23% | 15.37B | ||
| -0.48% | -2.30% | +22.36% | +187.62% | 14.09B | ||
| Average | -0.52% | -1.83% | +47.34% | +198.23% | 26.33B | |
| Weighted average by Cap. | +0.99% | -0.61% | +47.95% | +165.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 21.91M 15.59M 13.62M 12.59M 11.63M 1.5B 22.3M 150M 58.91M 733M 58.54M 57.25M 2.52B | 28.86M 20.53M 17.94M 16.58M 15.32M 1.97B 29.38M 198M 77.6M 966M 77.11M 75.41M 3.32B |
| Net income | -1.04M -739K -646K -597K -552K -71M -1.06M -7.12M -2.79M -34.77M -2.78M -2.72M -120M | -7.1M -5.05M -4.41M -4.08M -3.77M -485M -7.23M -48.65M -19.09M -237M -18.97M -18.55M -818M |
| Net Debt | -6.32M -4.49M -3.93M -3.63M -3.35M -432M -6.43M -43.3M -16.99M -211M -16.88M -16.51M -728M | -2.94M -2.09M -1.83M -1.69M -1.56M -201M -3M -20.18M -7.92M -98.52M -7.87M -7.69M -339M |
Employees
-

















